- MyIllumina
- Tools
The Small RNA Sample Preparation Kit provides reagents for sequencing of known and novel microRNAs as well as other non-coding RNAs or varying length, enabling size-focused or broad size range investigation of different classes of small RNA on one universal platform.
The kit selectively targets microRNA, or other polycistronic RNAs that have been processed by DICER or similar nucleases, which provide a distinct molecular signature. The RNA fragments are ligated to Illumina adapters followed by reverse transcription and PCR amplification. These libraries are ready to load on cBot or the Cluster Station for cluster generation.
Catalog IDs: FC-102-1009, FC-102-1010, FC-102-1013
View the product support page for additional technical information ยป
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.